Visit this section

At just 23 years old, David found himself facing the challenging combination of psychosis and heavy cannabis use.

Living with his parents and younger brother, he spent most of his time withdrawn from the world, relying on cannabis and video games as his primary sources of comfort.

Although his family had no history of schizophrenia, signs of social anxiety and difficulty connecting with others emerged early, which later escalated into a full-blown psychotic episode.

This initial episode, triggered by cannabis use, led to a 40-day hospitalization. Diagnosed with a psychotic disorder from the schizophrenia spectrum and cannabis misuse, David’s journey through treatment was filled with both encouraging progress and difficult setbacks.

His initial treatment focused on reducing symptoms like delusions and hallucinations, which responded well to medication. However, negative symptoms – such as a lack of motivation and apathy – remained.

Feeling stigmatized, David stopped his medication prematurely, resulting in a rapid relapse characterized by the return of psychotic symptoms and increased cannabis use.

This early phase of his treatment journey highlighted the difficulties of managing both mental health and substance use challenges. It also reinforced the need for consistent support from both medical professionals and loved ones.

When David returned to care, his condition had worsened. He experienced persistent delusions, hallucinations, and social isolation, alongside intense cravings for cannabis.

Initial treatment led to partial improvement in positive symptoms, but was held back by side effects, ultimately requiring a change in approach.

A new pharmacological strategy was implemented with a gradual transition between medications. Over several weeks, both his positive and negative symptoms eased, and his cravings diminished somewhat. His progress was not always steady, but with ongoing effort, he managed to abstain from cannabis for two months. By the fourth month, David regained some functionality and eventually started a job.

Despite the improvement in symptoms, David consistently refused non-pharmacological interventions, because of stigma. This resistance limited opportunities to address deeper social and psychological challenges, emphasising the importance of destigmatizing mental health care.

Fortunately, his family played a critical role in his recovery, offering emotional and practical support. Their involvement helped compensate for his limited engagement with professional psychosocial interventions, though this dynamic is not always present in similar cases.

David’s story, although ultimately showing encouraging outcomes, reflects the complex and often unpredictable path of treating schizophrenia spectrum disorders with comorbid substance use.

How well treatment works can be very different for each person, and relapses can occur even when progress seems promising.

David’s story reminds us that a personalized approach, combining medication, therapy, and family support, is often the most effective path forward.

It also highlights the need to break down stigma so that individuals facing similar challenges feel empowered to seek help without fear of judgment.

Recovery is not a straight line – it is a journey of resilience, patience, and adaptable care. Your love and support as caregivers are invaluable anchors on this journey.

Showing 0 result(s).